Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study

SIMPLE SUMMARY: Light-chain amyloidosis is a rare disease, and treatment for relapsed light-chain amyloidosis patients is an unmet need. Venetoclax is an oral medication that has proven great efficacy in many hematological cancers, including multiple myeloma. Venetoclax is considered a promising age...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebel, Eyal, Kastritis, Efstathios, Palladini, Giovanni, Milani, Paolo, Theodorakakou, Foteini, Aumann, Shlomzion, Lavi, Noa, Shargian, Liat, Magen, Hila, Cohen, Yael, Gatt, Moshe E., Vaxman, Iuliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046384/
https://www.ncbi.nlm.nih.gov/pubmed/36980596
http://dx.doi.org/10.3390/cancers15061710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046384/
https://www.ncbi.nlm.nih.gov/pubmed/36980596
http://dx.doi.org/10.3390/cancers15061710

Ejemplares similares